Director's Column
Clinical Intelligence Hub • Expert Curation
Dr. Tatiana Bosch's special editorial column on precision longevity medicine, biological asset preservation, and high-performance health strategy. We publish exclusive columns exploring cell therapies, circadian light, sleep optimization, and the neurobiology of joy.
Everything in this field pulls toward more: another course, another infusion, another marker moving the right way. The discipline that matters most is knowing when to stop. One patient taught me the difference.
After 15 years building clinical evidence, I now find myself practicing in a field where the evidence is still catching up. Mesenchymal cell therapy has thousands of registered trials, yet only 4 have reached Phase III or IV. This is an honest look at what we know, what remains uncertain, and how to think responsibly when science has not yet caught up with clinical possibility.
In a world of accelerating pace, dissolving boundaries, and 24/7 mental load, health is no longer a luxury: it is a strategic asset.
What is a stem cell, and why it will transform not only medicine but also our understanding of aging
Showing 1–4 of 4 briefings